Wed, September 13, 2023

Alex Thompson Reiterated (VRDN) at Strong Buy and Held Target at $40 on, Sep 13th, 2023

  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. -buy-and-held-target-at-40-on-sep-13th-2023.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
  • 🞛 This publication is a summary or evaluation of another publication
  • 🞛 This publication contains potentially derogatory content such as foul language or violent themes
Alex Thompson of Stifel, Reiterated "Viridian Therapeutics, Inc." (VRDN) at Strong Buy and Held Target at $40 on, Sep 13th, 2023.

Alex has made no other calls on VRDN in the last 4 months.



There are 7 other peers that have a rating on VRDN. Out of the 7 peers that are also analyzing VRDN, 0 agree with Alex's Rating of Hold.



These are the ratings of the 7 analyists that currently disagree with Alex


  • Douglas Tsao of "HC Wainwright & Co." Maintained at Strong Buy with Decreased Target to $37 on, Thursday, August 10th, 2023
  • Serge Belanger of "Needham" Maintained at Strong Buy with Decreased Target to $40 on, Thursday, August 10th, 2023
  • Leland Gershell of "Oppenheimer" Maintained at Buy with Decreased Target to $35 on, Wednesday, August 9th, 2023
  • Gregory Renza of "RBC Capital" Reiterated at Buy and Held Target at $44 on, Wednesday, August 9th, 2023
  • Jason Butler of "JMP Securities" Maintained at Buy with Decreased Target to $42 on, Wednesday, August 9th, 2023
  • Julian Harrison of "BTIG" Initiated at Strong Buy and Held Target at $46 on, Wednesday, June 14th, 2023
  • Tiago Fauth of "Credit Suisse" Initiated at Buy and Held Target at $51 on, Wednesday, June 14th, 2023